Display Settings:

Format

Send to:

Choose Destination

    Cornea. 2003 Jul;22(5):465-7.

    Inhibition of corneal neovascularization by genetic ablation of CCR2.

    Ambati BK, Joussen AM, Kuziel WA, Adamis AP, Ambati J.

    Department of Ophthalmology, Medical College of Georgia, Augusta, 30907, USA. bambati@mail.mcg.edu

    PURPOSE: To determine if genetic ablation of the chemokine receptor CCR2 (involved in leukocyte and endothelial chemotaxis) inhibits the development of corneal neovascularization. METHODS: Wild-type C57BL/6J mice, as well as species-specific counterparts with targeted homozygous disruption of the CCR2, underwent chemical and mechanical denudation of corneal and limbal epithelium. Corneas were harvested 2 weeks after injury. Neovascularization was quantified by CD31 immunostaining. RESULTS: The mean percentages of neovascularized corneal area in control mice and CCR2-deficient mice 2 weeks after denudation were 58.3% and 38.8% (P = 0.047), respectively. CONCLUSIONS: Development of corneal neovascularization is inhibited in CCR2-deficient mice.

    PMID: 12827053 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read